DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PHENYLBUTYRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHENYLBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BZL101
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BZL101
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SATOREOTIDE TRIZOXETAN
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
SATOREOTIDE TRIZOXETAN
×
Maximum Phase:
2
First Approval:
None
UNII:
3M7TX701A4
Molecule Type:
Protein
Molecular Formula:
C73H95ClN18O21S2
Molecular Weight:
1660.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BAMINERCEPT
2
Protein
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Multiple Sclerosis, Chronic Progressive; Arthritis, Rheumatoid; Sjogren's Syndrome
Heterotrimeric lymphotoxin LTa1b2 inhibitor
BAMINERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
HTV56CD308
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LX-2931
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
LX-2931
×
Maximum Phase:
2
First Approval:
None
UNII:
C5AGI979T7
Molecule Type:
Small molecule
Molecular Formula:
C9H15N3O5
Molecular Weight:
245.24
AlogP:
-1.64
PSA:
142.19
HBD:
6.0
HBA:
#RotB:
5.0
Source:
BIIB061
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis
Unknown
BIIB061
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SLV-334
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries
Unknown
SLV-334
×
Maximum Phase:
2
First Approval:
None
UNII:
3613ZP748K
Molecule Type:
Small molecule
Molecular Formula:
C33H36N2O6
Molecular Weight:
556.66
AlogP:
4.97
PSA:
124.01
HBD:
3.0
HBA:
#RotB:
10.0
Source:
PERFOSFAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neuroblastoma
Unknown
PERFOSFAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
U880A4FUDA
Molecule Type:
Small molecule
Molecular Formula:
C7H15Cl2N2O4P
Molecular Weight:
293.09
AlogP:
1.7
PSA:
71.03
HBD:
2.0
HBA:
#RotB:
6.0
Source:
MK-4721
2
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Carcinoma, Pancreatic Ductal; Digestive System Diseases
Prostate stem cell antigen inhibitor
MK-4721
×
Maximum Phase:
2
First Approval:
None
UNII:
L0505LPC7O
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KAI-1678
2
Unknown
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Pain; Spinal Cord Injuries
Protein kinase C epsilon inhibitor
KAI-1678
×
Maximum Phase:
2
First Approval:
None
UNII:
32P8I5VL5A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SPRIFERMIN
2
Protein
Investigational
Unknown
Unknown
Osteoarthritis; Osteoarthritis, Knee; Wounds and Injuries
Unknown
SPRIFERMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
UEJ4E476ZP
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AL-12182
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Prostanoid FP receptor agonist
AL-12182
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H35ClO6
Molecular Weight:
467.0
AlogP:
4.47
PSA:
85.22
HBD:
2.0
HBA:
#RotB:
13.0
Source:
CARBON MONOXIDE
2
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Ileus; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome
Unknown
CARBON MONOXIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
7U1EE4V452
Molecule Type:
Small molecule
Molecular Formula:
CO
Molecular Weight:
28.01
AlogP:
-0.04
PSA:
19.9
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PAQUINIMOD
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic; Scleroderma, Systemic
Unknown
PAQUINIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HB76GLG27V
Molecule Type:
Small molecule
Molecular Formula:
C21H22N2O3
Molecular Weight:
350.42
AlogP:
3.47
PSA:
62.54
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AMONAFIDE L-MALATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AMONAFIDE L-MALATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HALOFUGINONE HYDROBROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Sarcoma, Kaposi
Unknown
HALOFUGINONE HYDROBROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
PTC2969MV1
Molecule Type:
Small molecule
Molecular Formula:
C16H18Br2ClN3O3
Molecular Weight:
495.6
AlogP:
1.88
PSA:
84.22
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SELICICLIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung; Cystic Fibrosis; Pituitary ACTH Hypersecretion
Cyclin-dependent kinase 1 inhibitor
SELICICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0ES1C2KQ94
Molecule Type:
Small molecule
Molecular Formula:
C19H26N6O
Molecular Weight:
354.46
AlogP:
3.2
PSA:
87.89
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SODELGLITAZAR
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Metabolic Syndrome
Peroxisome proliferator-activated receptor agonist
SODELGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
6G973E04VI
Molecule Type:
Small molecule
Molecular Formula:
C23H21F4NO3S2
Molecular Weight:
499.55
AlogP:
7.12
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CADONILIMAB
2
Antibody
Investigational
Unknown
Unknown
Lung Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Nasopharyngeal Neoplasms; Neoplasms; Uterine Cervical Neoplasms
Cytotoxic T-lymphocyte protein 4 inhibitor
CADONILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMMONIUM TRICHLOROTELLURATE
2
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration; Alopecia; Condylomata Acuminata; Dermatitis, Atopic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Psoriasis
Unknown
AMMONIUM TRICHLOROTELLURATE
×
Maximum Phase:
2
First Approval:
None
UNII:
708681952A
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-911543
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Tyrosine-protein kinase JAK2 inhibitor
BMS-911543
×
Maximum Phase:
2
First Approval:
None
UNII:
7N03P021J8
Molecule Type:
Small molecule
Molecular Formula:
C23H28N8O
Molecular Weight:
432.53
AlogP:
3.5
PSA:
85.8
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OCTENIDINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Candidiasis; Eczema; Gingivitis; Tinea Pedis
Unknown
OCTENIDINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
U84956NU4B
Molecule Type:
Small molecule
Molecular Formula:
C36H64Cl2N4
Molecular Weight:
623.84
AlogP:
9.63
PSA:
34.58
HBD:
0.0
HBA:
#RotB:
25.0
Source:
TAVOKINOGENE TELSEPLASMID
2
Gene
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Melanoma; Mycosis Fungoides
Unknown
TAVOKINOGENE TELSEPLASMID
×
Maximum Phase:
2
First Approval:
None
UNII:
MF4P7VQ2K8
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BO-653
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BO-653
×
Maximum Phase:
2
First Approval:
None
UNII:
2VSP9T5LRX
Molecule Type:
Small molecule
Molecular Formula:
C26H44O2
Molecular Weight:
388.64
AlogP:
7.82
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CRIDANIMOD
2
Small molecule
Investigational
Unknown
Unknown
Endometrial Neoplasms
Unknown
CRIDANIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
X91E9EME19
Molecule Type:
Small molecule
Molecular Formula:
C15H11NO3
Molecular Weight:
253.26
AlogP:
2.24
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
IPAMORELIN
2
Protein
Investigational
Unknown
Unknown
Ileus
Unknown
IPAMORELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Y9M3S784Z6
Molecule Type:
Protein
Molecular Formula:
C38H49N9O5
Molecular Weight:
711.87
AlogP:
0.88
PSA:
240.21
HBD:
8.0
HBA:
#RotB:
19.0
Source:
RIVOGENLECLEUCEL
2
Cell
Investigational
Unknown
Unknown
Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
RIVOGENLECLEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
E6349B696W
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LENIOLISIB PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Common Variable Immunodeficiency; Sjogren's Syndrome
Unknown
LENIOLISIB PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3700M1H39Q
Molecule Type:
Small molecule
Molecular Formula:
C21H28F3N6O6P
Molecular Weight:
548.46
AlogP:
2.88
PSA:
83.48
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GSK-1292263
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Lipid Metabolism Disorders
Glucose-dependent insulinotropic receptor agonist
GSK-1292263
×
Maximum Phase:
2
First Approval:
None
UNII:
R1J57STA6O
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O4S
Molecular Weight:
456.57
AlogP:
3.95
PSA:
98.42
HBD:
0.0
HBA:
#RotB:
7.0
Source:
CRS-207
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CRS-207
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OMACETAXINE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
OMACETAXINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIRICODAR
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIRICODAR
×
Maximum Phase:
2
First Approval:
None
UNII:
3KG76X4KJK
Molecule Type:
Small molecule
Molecular Formula:
C34H41N3O7
Molecular Weight:
603.72
AlogP:
5.02
PSA:
117.15
HBD:
0.0
HBA:
#RotB:
15.0
Source:
AVAGACESTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Gamma-secretase inhibitor
AVAGACESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
TQ44WWY45Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17ClF4N4O4S
Molecular Weight:
520.89
AlogP:
3.92
PSA:
119.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CALDARET
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CALDARET
×
Maximum Phase:
2
First Approval:
None
UNII:
9L3Y3IJ2HI
Molecule Type:
Small molecule
Molecular Formula:
C11H16N2O3S
Molecular Weight:
256.33
AlogP:
0.65
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
2.0
Source:
STAMULUMAB
2
Antibody
Investigational
Unknown
Unknown
Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Muscular Dystrophy, Facioscapulohumeral
Growth/differentiation factor 8 inhibitor
STAMULUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
V43X8G4797
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
134
135
136
137
138
139
140
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA